Loading...
Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection
A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxacin (400 mg) following a once-daily oral administration in 28 patients with respiratory tract infection disease. The maximum plasma concentration and the area under the plasma concentration–time curve...
Na minha lista:
| Udgivet i: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933663/ https://ncbi.nlm.nih.gov/pubmed/26660898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815620338 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|